Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors.